A Study of TRS01 in Participants With Post-surgical Ocular Inflammation

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Post Surgical Ocular Inflammation

In brief

The objective of this study is to evaluate the safety and preliminary efficacy of TRS01 eye drops as compared to placebo on participants with ocular inflammation after cataract surgery.

Key facts

Study ID
NCT04222725
Run by
Tarsier Pharma
People needed
37
Starts
2020-02-01
Expected to finish
2020-07-17
Last updated by the study team
2021-10-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.